SEEIIST Association, Rue de Battoirs 7, c/o PKF Fiduciaire SA, 1205 Geneva Switzerland

Author: seeiist

SEEIIST 3-D DESIGN

Video clip is based on the 3-D design of SEEIIST, which was sponsored by the Ministry of Montenegro together with CERN

Forging Frontiers in Science: SEEIIST’s Role at the I.FAST Annual Meeting

In a significant display of scientific collaboration and progress, SEEIIST’s own Luca Garolfi presented at the I.FAST annual meeting, marking a momentous occasion for our institute. The presentation emphasized our ongoing projects and the strides we are making in the field of sustainable technologies. Garolfi’s speech touched upon the institute’s Read More…

Particle Therapy MasterClasses 2024

The Particle Therapy MasterClass (PTMC), that was introduced in 2020, is a hands-on educational activity, addressing high-school students, which demonstrates direct applications of fundamental sciences, in particular physics, for the benefit of society, focusing on the treatment of cancer tumours with charged particles. The PTMC is integrated in the International Read More…

Call for Applications: Challenged Based Innovation Program

An Opportunity for a  SEEIIST Student Sponsored by HITRIplus We are excited to announce a unique opportunity for a student from SEEIIST member states, supported by HITRIplus. Join us in the journey of innovation and discovery through the Challenged Based Innovation Program. Program Overview The Challenged Based Innovation Program is Read More…

Tags:

12th Seminar of HITRIplus – New trends and initiatives in accelerators for ion therapy of cancer, Maurizio Vretenar, CERN

📢We are excited to announce that the 12th HITRIplus seminar is coming up, and we have a very special guest speaker joining us. Maurizio Vretenar, from CERN, will be presenting on an intriguing topic that you won’t want to miss! 👀 “New trends and initiatives in accelerators for ion therapy of cancer” Read More…

Tags:

HITRIplus seminar – 20.04.2023 17pm – LIGHT: a linear accelerator for cancer therapy, AVO-ADAM

The next exciting HITRIplus https://www.hitriplus.eu/ seminar will take place on Thursday, April 20, 2023, from 17.00 CET. Alberto Degiovanni, Anna Maria Kolano and Stephen Myers will present LIGHT: a linear accelerator for cancer therapy (Advanced Oncotherapy, https://www.avoplc.com/en-gb/ ). We would be delighted to have your participation. Please forward and share this information with those who might be interested in attending the seminar. Read More…

SPECIALISED COURSE ON CLINICAL ASPECTS OF HEAVY ION CANCER THERAPY RESEARCH

We are pleased to announce a one-week online international specialised course on Clinical Aspects of Heavy Ion Cancer Therapy Research which will be held from the 3rd to the 7th of July 2023, online on Zoom; see https://indico.cern.ch/event/1248018/ It is free of charge and is funded by the European Union’s H2020 research and innovation programme through the HITRIplus project https://www.hitriplus.eu/. This Read More…

Tags:

STRONG POLITICAL SUPPORT FOR THE PROJECT REALIZATION

BERN, SWITZERLAND, September 13-15. The high-level event A Science Diplomacy Roadmap for South East Europe – The Example of SEEIIST was organized by the SEEIIST Steering Committee and Swiss Federal Department for Foreign Affairs (FDFA). The aim of the conference was to summarise the status of the SEEIIST project initiative and Read More…

The Fourth meeting of the Steering Committee, Vienna, 27 November 2018

The Fourth meeting of the SEEIIST Steering Committee was held at the premises of the International Atomic Energy Agency (IAEA) in Vienna on 27 November 2018. For the first time the SEEIIST SC Meeting had an Open session, attended by representatives of the IAEA, the European Commission DG RTD, CERN, Read More…

SEEIIST project is getting its LOGO

Thanks to the proposal of a member of the SEEIIST Steering Committee, Prof. Mimoza Ristova at the University ‘Sc. Cyril and Methodius’ in Skopje, the project has now received a nice proposal for the logo. The design combines the SEEIIST project with the Bragg peaks, characteristic for the dose deposition Read More…